BRAIN CCK-B RECEPTORS MEDIATE THE SUPPRESSION OF DOPAMINE RELEASE BY CHOLECYSTOKININ

被引:52
作者
ALTAR, CA [1 ]
BOYAR, WC [1 ]
机构
[1] CIBA GEIGY CORP,DIV PHARMACEUT,SUMMIT,NJ 07901
关键词
D O I
10.1016/0006-8993(89)90176-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:321 / 326
页数:6
相关论文
共 46 条
[1]   CHOLECYSTOKININ ATTENUATES BASAL AND DRUG-INDUCED INCREASES OF LIMBIC AND STRIATAL DOPAMINE RELEASE [J].
ALTAR, CA ;
BOYAR, WC ;
OEI, E ;
WOOD, PL .
BRAIN RESEARCH, 1988, 460 (01) :76-82
[2]  
[Anonymous], 1971, STAT PRINCIPLES EXPT
[3]   REVERSAL BY CHOLECYSTOKININ OF APOMORPHINE-INDUCED INHIBITION OF DOPAMINE RELEASE IN THE NUCLEUS-ACCUMBENS OF THE RAT [J].
BLAHA, CD ;
PHILLIPS, AG ;
LANE, RF .
REGULATORY PEPTIDES, 1987, 17 (06) :301-310
[5]  
CHANG RSL, 1986, MOL PHARMACOL, V30, P212
[6]   ELECTROPHYSIOLOGICAL STUDIES ON THE SPECIFICITY OF THE CHOLECYSTOKININ ANTAGONIST PROGLUMIDE [J].
CHIODO, LA ;
FREEMAN, AS ;
BUNNEY, BS .
BRAIN RESEARCH, 1987, 410 (02) :205-211
[7]   CHOLECYSTOKININ-OCTAPEPTIDE EFFECTS ON CONDITIONED-AVOIDANCE BEHAVIOR, STEREOTYPY AND CATALEPSY [J].
COHEN, SL ;
KNIGHT, M ;
TAMMINGA, CA ;
CHASE, TN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 83 (3-4) :213-222
[8]  
COSI C, UNPUB NEUROPHARMACOL
[9]   DESIGN OF POTENT, ORALLY EFFECTIVE, NONPEPTIDAL ANTAGONISTS OF THE PEPTIDE-HORMONE CHOLECYSTOKININ [J].
EVANS, BE ;
BOCK, MG ;
RITTLE, KE ;
DIPARDO, RM ;
WHITTER, WL ;
VEBER, DF ;
ANDERSON, PS ;
FREIDINGER, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (13) :4918-4922
[10]   THE ORIGIN OF CHOLECYSTOKININ TERMINALS IN THE BASAL FOREBRAIN OF THE RAT - EVIDENCE FROM IMMUNOFLUORESCENCE AND RETROGRADE TRACING [J].
FALLON, JH ;
HICKS, R ;
LOUGHLIN, SE .
NEUROSCIENCE LETTERS, 1983, 37 (01) :29-35